Skip to nav Skip to content

News Releases and Statements

Facebook Twitter LinkedIn Email

Infectious Diseases Specialists Call on Public to Wear a Mask, Slow the Spread of COVID-19

As the number of COVID-19 cases in the United States continues to climb, the Infectious Diseases Society of America and its HIV Medicine Association implore the public to take the only simple and effective steps we have to slow the spread of the coronavirus and save lives – key among them, wear a mask.

Newer Therapy Recommended For Treatment-Refractory Mac Pulmonary Inefection

A newer therapy that acts like a Trojan horse to attack bacteria should be reserved for patients with certain treatment-refractory lung infections, according to updated nontuberculous mycobacterial (NTM) pulmonary disease guidelines released by the IDSA, the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the European Society of Clinical Microbiology and Infectious Disease (ESCMID).

IDSA Awarded CDC Grant for COVID-19 Support for Health Care Workers

As the COVID-19 pandemic continues to challenge health care professionals across the nation, the IDSA and the CDC have partnered to build connections across health care disciplines and to provide access to the latest information on fighting the disease that has ended the lives of more than 100,000 Americans and affected even more.

CDC Experts Need More Involvement in COVID-19, Not Less

Reports that the White House may be considering significantly reducing the role of the Centers for Disease Control and Prevention are deeply concerning. America remains at the center of a global pandemic and needs well-established, credible scientists—not political appointees—informing public health decisions.

Withdrawal of Transgender Protections in ACA Reinforces Health Care Inequities

The rules in the Patient Protection and Affordable Care Act barring discrimination by health insurers and providers against transgender people offered essential protections for a population facing significant barriers to health care.

Re-openings, Protests Highlight Need for Renewed Attention to COVID-19 Precautions, Prevention, Preparedness

As strict stay-at-home orders are suspended in states across the country and mass calls for racial justice continue to bring large numbers of people together, individual protective measures as well as responsive public policies and resources will be paramount to controlling the spread of COVID-19.

Counties With Greatest COVID-19 Caseloads Have Few or No Infectious Diseases Physicians

As the numbers of physicians specializing in infectious diseases continues to fall short of need, nearly two-thirds of Americans live in areas with little or no access to an infectious diseases specialist, according to a study published online today in the Annals of Internal Medicine.

Response to the Death of George Floyd

The incomprehensible death of George Floyd has left our country grieving and demands attention to the environment of disparities, inequities and structural racism in which it occurred. As infectious diseases and HIV health care providers, we stand against discrimination in any form.

IDSA, HIVMA Ask Ambassador Birx to Meet on Remdesivir Distribution Questions

Meeting requested to address questions, inform planning for use of remdesivir, the only FDA-authorized drug for COVID-19 treatment.

Health Heroes Act Addresses Critical COVID-19 Needs, Should be Strengthened

H.R.6800, the Health Heroes Act, includes policies and investments that would bolster the federal response to COVID-19, increase testing capacity and availability of medical supplies and address the disparate impact of COVID-19 on vulnerable populations.

Remdesivir Distribution to States is a Step in the Right Direction but Transparency Remains Paramount

The U.S. Department of Health and Human Services decision allowing state health departments to distribute limited supplies of remdesivir to treat COVID-19 where they are needed will support fair and equitable access to the drug.

With Lives at Stake, IDSA calls on White House to Follow and Support the Guidance of Our Nation’s Public Health Experts

Strong and specific federal guidance is critical to protecting our country, our communities, our health and our lives in the face of the still escalating impacts of COVID-19 across the United States.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.